![Win for AstraZeneca as Symbicort gains six months of pediatric exclusivity in the US - Pharmaceutical Technology Win for AstraZeneca as Symbicort gains six months of pediatric exclusivity in the US - Pharmaceutical Technology](https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2017/09/main-188-296x200.png)
Win for AstraZeneca as Symbicort gains six months of pediatric exclusivity in the US - Pharmaceutical Technology
![A current update on advanced drug delivery devices for nasal and pulmonary administration - ScienceDirect A current update on advanced drug delivery devices for nasal and pulmonary administration - ScienceDirect](https://ars.els-cdn.com/content/image/3-s2.0-B9780128198384000031-f11-02-9780128198384.jpg)
A current update on advanced drug delivery devices for nasal and pulmonary administration - ScienceDirect
![Comparing LAMA with LABA and LTRA as add-on therapies in primary care asthma management | npj Primary Care Respiratory Medicine Comparing LAMA with LABA and LTRA as add-on therapies in primary care asthma management | npj Primary Care Respiratory Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41533-020-00205-9/MediaObjects/41533_2020_205_Fig1_HTML.png)
Comparing LAMA with LABA and LTRA as add-on therapies in primary care asthma management | npj Primary Care Respiratory Medicine
![Comparing LAMA with LABA and LTRA as add-on therapies in primary care asthma management. - Abstract - Europe PMC Comparing LAMA with LABA and LTRA as add-on therapies in primary care asthma management. - Abstract - Europe PMC](https://europepmc.org/articles/PMC7658210/bin/41533_2020_205_Fig4_HTML.jpg)
Comparing LAMA with LABA and LTRA as add-on therapies in primary care asthma management. - Abstract - Europe PMC
![Role of dual and triple fixed-dose combination inhalers in the treatment of chronic obstructive pulmonary disease - The Pharmaceutical Journal Role of dual and triple fixed-dose combination inhalers in the treatment of chronic obstructive pulmonary disease - The Pharmaceutical Journal](https://pharmaceutical-journal.com/wp-content/uploads/2021/01/Figure-1-COPD-revie_544.png)
Role of dual and triple fixed-dose combination inhalers in the treatment of chronic obstructive pulmonary disease - The Pharmaceutical Journal
![PDF) Role of dual and triple fixed-dose combination inhalers in the treatment of chronic obstructive pulmonary disease PDF) Role of dual and triple fixed-dose combination inhalers in the treatment of chronic obstructive pulmonary disease](https://i1.rgstatic.net/publication/329760526_Role_of_dual_and_triple_fixed-dose_combination_inhalers_in_the_treatment_of_chronic_obstructive_pulmonary_disease/links/60135c6b92851c2d4dfed8c9/largepreview.png)